Stefania Pittaluga

Author PubWeight™ 2.29^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL.	Blood	2014	2.40